Investigational anticoagulants for hematological conditions: a new generation of therapies

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.10, 2013-10, pp. : 1281-1294

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beyond heparin and warfarin: the new generation of anticoagulants

By Weitz Jeffrey I Linkins Lori-Ann

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 3, 2007-03 ,pp. : 271-282

Informa Healthcare

Access to resources Recommend Favorite

Investigational therapies for acromegaly

By Grasso Ludovica FS

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 8, 2013-08 ,pp. : 955-963

Informa Healthcare

Access to resources Recommend Favorite

Investigational anabolic therapies for osteoporosis

By Trivedi Ritu Goswami Ravinder Chattopadhyay Naibedya

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 8, 2010-08 ,pp. : 995-1005

Informa Healthcare

Access to resources Recommend Favorite

Investigational Therapies for Metastatic Thyroid Carcinoma

By Tuttle R. Michael Leboeuf R.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 6, 2007-07 ,pp. : 641-646

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Investigational antibody-drug conjugates for hematological malignancies

By Polson Andrew G Ho William Y Ramakrishnan Vanitha

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 1, 2011-01 ,pp. : 75-85

Informa Healthcare

Access to resources Recommend Favorite